HomeGenetics UnderstandingInheritanceWhat are reduced penetrance and variable expressivity?
Back to Inheritance
What are reduced penetrance and variable expressivity?
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Inheritance

What are reduced penetrance and variable expressivity?

Reduced penetrance and variable expressivity are factors that influence how genetic variants manifest as signs and symptoms in an individual.

Reduced Penetrance

Penetrance refers to the proportion of people with a particular genetic variant who exhibit signs and symptoms of a disorder. If some people with the variant do not develop any features of the condition, it is called reduced (or incomplete) penetrance.

This is often seen in familial cancer syndromes. For example, many people with a variant in the BRCA1 or BRCA2 gene will develop cancer, but some will not. Because the cause—a combination of genetic, environmental, and lifestyle factors—is often unknown, it can be challenging for professionals to predict who will develop the condition.

Variable Expressivity

Variable expressivity refers to the range of signs and symptoms that can occur in different people with the same genetic condition. While some disorders show little variation, most exhibit a spectrum of severity.

For example, in Marfan syndrome, individuals with a variant in the FBN1 gene may experience vastly different symptoms. Some may only have mild features, such as being tall and thin with long fingers, while others may face life-threatening complications involving the heart and blood vessels. Like reduced penetrance, this variation is likely caused by a combination of unidentified genetic, environmental, and lifestyle factors, which can make diagnosis difficult.

Frequently Asked Questions

Incomplete penetrance means that not every person who carries the pathogenic variant will develop the disease. Your real-world risk is expressed as a penetrance percentage across a lifespan. For instance, if a mutation has an 80 percent penetrance by age 70, you have an 80 percent chance of developing signs of the condition and a 20 percent chance of remaining symptom-free. Clinicians combine your specific mutation with personal lifestyle factors, environmental exposures, and secondary modifier genes to estimate your individual lifetime risk.
When an autosomal dominant mutation exhibits reduced penetrance, an individual can inherit the altered gene and pass it to their children without ever developing symptoms themselves. On a family health tree, the disease appears to skip that healthy carrier parent, jumping directly from grandparent to grandchild. This can lead families to mistakenly assume the condition is not hereditary, which is why clinical geneticists test asymptomatic intermediate relatives during pedigree evaluations.
This occurs due to variable expressivity. While both siblings carry identical primary genetic alterations, the rest of their genetic backgrounds differ by roughly 50 percent. Variations in other background genes (known as genetic modifiers), differences in epigenetic regulation (how genes are turned on or off), and varied environmental exposures or health habits alter how intensely the primary variant manifests, resulting in mild symptoms in one sibling and severe complications in the other.
symptomatic carriers are placed on risk-stratified surveillance plans. Depending on the condition, this may involve earlier and more frequent screening (such as cardiac MRIs or endoscopies), preventive medications, avoidance of specific environmental or pharmacological triggers, or risk-reducing surgical options (such as preventive mastectomy or salpingo-oophorectomy for BRCA carriers). Regular follow-up with specialized medical teams ensures that any early sign of disease is detected and treated immediately.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

kontakt@hittavard.se

Ⓒ 2024. Alla rättigheter förbehålls av juxt ab

Sök
Om ossVillkor och policyVanliga frågorKontakta oss